21 records, the earliest from 15 Nov 2010. As filed with the exchanges; the history is only as deep as the data Tradinity has collected.
21 shown.
Sign in to see more, or upgrade your plan to see the full history. Sign in
| Date | Category | Subject |
|---|---|---|
| 24 Apr 2017 15:02 | Delisting | Members of the Exchange are hereby notified that in terms of Regulation 22(6) of the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations, 2009 (Regulations), Section 21A of the Securities Contract (Regulations) Act, 1956, Securities Contract Regulations Rules, 1957 and Bye Laws and Regulations of National Stock Exchange of India Limited (Exchange) it has been decided to delist (withdraw the admission to dealings in) equity shares of the Ankur Drugs And Pharma Limited w.e.f. May 12, 2017 as per SEBI (Delisting of Equity Shares) Regulations, 2009. |
| 7 Dec 2016 07:21 | Public Notice - Compulsory Delisting | Members of the Exchange are hereby informed that the Exchange on December 04, 2016 has issued public notice in the newspaper for compulsory delisting of equity shares of the company, in term of Regulation 22 (3) of SEBI (Delisting of Equity shares) Regulation, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/common/CorporateAnnouncements). |
| 6 Sep 2013 13:06 | Suspension of trading in equity shares | Members of the Exchange are hereby informed that trading in the equity shares of Ankur Drugs And Pharma Limited will be suspended w.e.f. September 11, 2013 (i.e. closing hours of trading on September 10, 2013) as the company has failed to respond to the notices of the Exchange for non-compliance with the provisions of listing agreement. It may also be noted that the Official Liquidator of Hon'ble High Court of Bombay, has informed the Exchange that, by an order dated 08-07-2013 passed by Hon'ble High Court of Bombay in C P No: 103 of 2012, Ankur Drugs And Pharma Limited shall be wound up and the Official Liquidator has been directed to take possession. |
| 2 Sep 2013 13:26 | Updates | Ministry of Corporate Affairs has informed the Exchange regarding an order dated 8/7/2013 passed by the Hon'ble Court in Company Petition No. 103 of 2012 in the matter of Ankur Drugs and Pharma Ltd. |
| 1 Jul 2013 05:18 | Resignation of Director | Ankur Drugs And Pharma Limited has informed the Exchange that the Board of Directors of the company at its meeting held on June 29, 2013 has taken the following decision: 1) Resignation of Mr. Anil Kumar Khadke as Nominee Director of Central Bank of India w.e.f March 15, 2013 has been accepted by the Board. |
| 26 Jun 2013 10:00 | Price movement | Price movement : Significant price movement has been observed in Ankur Drugs And Pharma Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Ankur Drugs And Pharma Limited has vide its letter inter-alia stated, "In this connection we have to advice that no activity influencing the price movement of scrip is taking place in the Company. The volatility in the movement of the scrip price is purely market driven and Company in nowhere involved in the same." |
| 22 May 2013 03:42 | Updates | Ankur Drugs And Pharma Limited has informed the Exchange that"FCCB holders had filed a petition challanging the scheme of arrangement proposed by the Company before the Hon'ble High Court of the judicature of Bombay. The Hon'ble High Court of the judicature of Bombay vide their order dated May 21, 2013 has stayed the holding of the meeting of Equity Shareholders, Secured Creditors, Unsecured and other Creditors, FCCB holders and Depositors of Ankur Drugs and Pharma Ltd scheduled for Wednesday the 22nd May, 2013 and Friday the 24th May, 2013, respectively till further orders." |
| 15 May 2013 14:30 | Court Convened Meeting Updates | Ankur Drugs And Pharma Limited has submitted to the Exchange a copy of the Notices for holding meetings of Equity Shareholders, Secured Creditors, Unsecured Creditors, Other Creditors, FCCB Holders and Depositors of the Company to be held on May 22, 2013. |
| 18 Apr 2013 14:22 | Updates | Ankur Drugs And Pharma Limited has informed the Exchange that the Company had received Order from Hon'ble High Court dated March 15, 2013, directing the Company to hold Meeting of Equity Shareholders and Secured Creditors on April 20, 2013 and Meeting of Unsecured and other Creditors, FCCB Holders and Depositors on April 22, 2013 in respect of Scheme of Arrangement and Compromise filed by the Company. Further, the Company had filed an application to Hon'ble Court Bombay for extending time period for holding meeting of Shareholders and Creditors and in this respect, Hon'ble High Court, Bombay have accepted application of the Company and have directed the Company to hold Meeting Equity Shareholders and Secured Creditors on May 22, 2013 and Meeting of Unsecured and other Creditors, FCCB Holders and Depositors on May 24, 2013. |
| 16 Apr 2013 06:50 | Updates | Ankur Drugs And Pharma Limited has informed the Exchange vide letter dated April 15, 2013 that the Company had received Order from Hon'ble High Court dated March 15, 2013 in respect of Scheme of Arrangement and Compromise filed by the Company. In the said Order Hon'ble High Court have directed the Company to Convene Meeting of Creditors and Shareholders to take approval on Scheme of Arrangement and Compromise as proposed by the Company. The Company is in process of making arrangement to convene meeting of creditors and shareholders. |
Disclosures are shown as filed with the exchanges; Tradinity does not verify them. Nothing here is investment advice.
